Hideki Motoyama

Kobe Medical Center, Kobe City Nishi-Kobe Medical Center

Papers

Total Citations

H-Index

About

Hideki Motoyama is a pioneering thoracic surgeon whose research focuses on advancing surgical strategies for lung cancer and mediastinal tumors. His major contributions lie at the intersection of immunotherapy and minimally invasive surgery, particularly in exploring salvage surgery after immune checkpoint inhibitor (ICI) therapy for initially unresectable non-small cell lung cancer (NSCLC). His 2024 study on this topic, with 6 citations, provides critical insights into patient outcomes and surgical feasibility following ICI treatment—a rapidly evolving area in oncology. Additionally, Motoyama has innovated in robotic-assisted thoracoscopic surgery (RATS), notably describing the prone position approach for posterior mediastinal tumors, as detailed in his 2025 paper. This work addresses the challenge of accessing confined anatomical spaces, offering a novel alternative to the traditional lateral decubitus position. While his citation counts are still growing, reflecting the recency of his work, Motoyama’s research is already shaping clinical practice by expanding surgical options for complex cases. His achievements highlight a commitment to integrating cutting-edge immunotherapy with advanced surgical techniques, making him a rising voice in thoracic oncology and robotic surgery.